Love your neighbour as thyself
ETSC Nepal
  • Link to Facebook
  • Link to Mail
  • Link to Youtube
  • Link to X
  • Home
  • DRR Portal
    • CSP
    • Knowledge & Information
    • Publication
      • DRR Strategic Plan
      • DRR Manual
      • Handbook for Lightning
  • EES
  • Childrens
  • Projects
    • Community Health First-Nepal
    • Educational Support
    • Empowering the Vulnerable people in Makwanpur
    • HIV/AIDS prevention
    • Food Security
    • Livelihood & Income generation
    • Peace Building Initiative
    • SAHAYATRA
    • Stop the Traffic End Slavery
    • Women Empowerment
  • Reports
  • News & Stories
    • Case Studies
    • Success Stories
  • Contact
  • ETSC Team
  • Menu Menu

Archive for category: public

You are here: Home1 / News & Stories2 / public

Coronavirus disease 2019

public

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

June 2, 2026/by etscn3pal
http://etscn.org.np/wp-content/uploads/2020/03/logo-1.png 0 0 etscn3pal http://etscn.org.np/wp-content/uploads/2020/03/logo-1.png etscn3pal2026-06-02 10:07:502026-06-02 10:07:54Coronavirus disease 2019

Coronavirus disease 2019

public

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

June 1, 2026/by etscn3pal
http://etscn.org.np/wp-content/uploads/2020/03/logo-1.png 0 0 etscn3pal http://etscn.org.np/wp-content/uploads/2020/03/logo-1.png etscn3pal2026-06-01 12:45:302026-06-01 12:49:14Coronavirus disease 2019

Coronavirus disease 2019

public

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

May 31, 2026/by etscn3pal
http://etscn.org.np/wp-content/uploads/2020/03/logo-1.png 0 0 etscn3pal http://etscn.org.np/wp-content/uploads/2020/03/logo-1.png etscn3pal2026-05-31 23:52:252026-05-31 23:56:08Coronavirus disease 2019

Categories

  • ! Без рубрики
  • 11
  • 24
  • 25
  • casino
  • Computers, Games
  • DRR
  • Forex News
  • News
  • Personal
  • public
  • Uncategorized

Archives

Facebook

Instagram

Follow Me!
  • Whales: Giants of the Ocean
  • Whales: Giants of the Ocean
  • Coronavirus disease 2019
  • Bet Alice Casino Gaming Club: Membership Perks Review for Canadian Players
  • Betano Casino Ontario: Unlocking Bonuses with the Best Promo Code for 2024

ETSC Nepal

You are welcome to extend helping hands in the mission of the ETSC-Nepal.

  • About Us
  • Our Team
  • Success Stories

Project

  • DRR
  • EES
  • EVPM

Contact Us

  • Hetauda-15,Farline
  • Tel 977-57-523375
  • Cell: 9819259624
  • Email:etscnpl1@gmail.com
  • Toll Free(NCELL):+977-9801571371
© Copyright - ETSC Nepal
  • Link to Facebook
  • Link to Mail
  • Link to Youtube
  • Link to X
Scroll to top Scroll to top Scroll to top